Related Experiment Video
Updated: Nov 10, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection
Anja Forrer1, Felix Schoenrath2,3, Michael Torzewski4
1Institute of Clinical Chemistry, University Hospital of Zurich, University of Zurich, 8091 Zurich, Switzerland.
Insights
Researchers identified potential blood biomarkers for acute aortic dissection (AAD). Interleukin-10 (IL-10) shows promise as a rule-in biomarker, while a combination of D-dimers, hs-TnT, IL-6, and PAI1 improves diagnosis accuracy.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Medical Diagnostics
Background:
- Acute aortic dissection (AAD) is a life-threatening cause of chest pain, lacking specific diagnostic blood tests.
- Differential diagnosis of acute chest pain often involves acute myocardial infarction (AMI) and pulmonary embolism (PE).
Purpose of the Study:
- To identify novel plasma biomarkers for the diagnosis of acute aortic dissection (AAD).
- To evaluate the diagnostic performance of identified biomarkers, individually and in combination, for AAD.
Main Methods:
- Proseek® Multiplex assays were used to screen plasma samples from patients with AAD, AMI, PE, thoracic aortic aneurysm (TAA), and non-cardiovascular chest pain (nonCVD).
- Top candidate biomarkers were validated using conventional immunoassays and their expression analyzed in aortic tissue.
Main Results:
- Interleukin-10 (IL-10) demonstrated high specificity (98%) and moderate sensitivity (55%) for AAD diagnosis.
- A panel including D-dimers, high-sensitive troponin T (hs-TnT), interleukin-6 (IL-6), and plasminogen activator inhibitor 1 (PAI1) achieved 83% sensitivity and 95% specificity for AAD detection.
- This biomarker combination correctly classified 77% of all patient cases.
Conclusions:
- IL-10 presents potential as a specific rule-in biomarker for AAD.
- Combining IL-6 and PAI1 with hs-TnT and D-dimers may enhance the differentiation of AAD from other acute chest pain causes like AMI and PE.
Abstract:
Acute aortic dissection (AAD) is a rare condition, but together with acute myocardial infarction (AMI) and pulmonary embolism (PE) it belongs to the most relevant and life-threatening causes of acute chest pain. Until now, there has been no specific blood test in the diagnostic workup of AAD. To identify clinically relevant biomarkers for AAD, we applied Proseek® Multiplex assays to plasma samples from patients with AAD, AMI, PE, thoracic aortic aneurysm (TAA), and non-cardiovascular chest pain (nonCVD). Subsequently, we validated top hits using conventional immunoassays and examined their expression in the aortic tissue. Interleukin 10 (IL-10) alone showed the best performance with a sensitivity of 55% and a specificity of 98% for AAD diagnosis. The combination of D-dimers, high-sensitive troponin T (hs-TnT), interleukin 6 (IL-6), and plasminogen activator inhibitor 1 (PAI1) correctly classified 75% of AAD cases, delivering a sensitivity of 83% and specificity of 95% for its diagnosis. Moreover, this model provided the correct classification of 77% of all analyzed cases. Our data suggest that IL-10 shows potential to be a rule-in biomarker for AAD. Moreover, the addition of PAI1 and IL-6 to hs-TnT and D-dimers may improve the discrimination of suspected AAD, AMI, and PE in patients presenting with acute chest pain.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

